P McCulloch, A Choy, AD Purushotham… - Journal of surgical …, 1994 - Wiley Online Library
One aspect of the metastatic process involves entrapment of tumor cells within the microcirculation of organs in a “fibrin‐platelet mesh.” We postulate that destruction of this …
CA Kristensen, PB Jensen, HS Poulsen… - Critical reviews in …, 1996 - Elsevier
A&WWWIS: A, doxorubkin; Al&IT, autoiogous bone marrow transplantation; ACNU, see N beiow; ACTH. adrenocorticotropk hormone; ADH. ttddbtk htt~ t~ AN, absolute neutrophik …
V Bobek, D Pinterova, K Kolostova, M Boubelik… - Cancer letters, 2006 - Elsevier
The aim was to determine the effect of fybrinolytic therapy by streptokinase on chemotherapy and radiation response in human colon cancer cells. The cells were treated with different …
LR Zacharski - Translational lung cancer research, 2016 - ncbi.nlm.nih.gov
Numerous studies have shown that elements of coagulation reactions mediate tumor cell proliferation, motility (invasiveness), tissue remodeling and metastasis. Coagulation …
Urokinase-type plasminogen activator has been administered by other investigators to patients with small cell carcinoma of the lung (SCCL) in an attempt to induce lysis of fibrin …
LR Zacharski, WG Henderson - Thrombosis and haemostasis, 2002 - thieme-connect.com
1TQ ietters to the Editor because it is used commonly in patients with malignancy complicated by deep vein thrombosis and can be given chronically on an outpatient basis …
G Lugassy, A Klepfish - Thrombosis and Cancer, 2004 - taylorfrancis.com
The fibrinolytic system in cancer Page 1 5 The fibrinolytic system in cancer Gilles Lugassy and Abraham Klepfish The fibrinolytic (plasminogen–plasmin proteolytic enzyme) system is …
CPW Klerk, SM Smorenburg… - Thrombosis and cancer …, 2004 - books.google.com
Because of the high risk of thrombosis, cancer patients often receive anticoagulants as prophylaxis or treatment. It has been suggested that antithrombotic agents influence cancer …